
Chlorotriphenylmethane
CAS No. 76-83-5
Chlorotriphenylmethane( NSC 435 | NSC-435 | NSC435 | TriphenylMethyl chloride )
Catalog No. M27284 CAS No. 76-83-5
Chlorotriphenylmethane is a biochemical substance.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 45 | In Stock |
![]() ![]() |
10MG | 68 | In Stock |
![]() ![]() |
25MG | 115 | In Stock |
![]() ![]() |
50MG | 173 | In Stock |
![]() ![]() |
100MG | 258 | In Stock |
![]() ![]() |
200MG | 388 | In Stock |
![]() ![]() |
500MG | 642 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameChlorotriphenylmethane
-
NoteResearch use only, not for human use.
-
Brief DescriptionChlorotriphenylmethane is a biochemical substance.
-
DescriptionChlorotriphenylmethane is a biochemical substance.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC 435 | NSC-435 | NSC435 | TriphenylMethyl chloride
-
PathwayOthers
-
TargetOther Targets
-
RecptorP2X3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number76-83-5
-
Formula Weight278.78
-
Molecular FormulaC19H15Cl
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESClC(c1ccccc1)(c1ccccc1)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kai H, et al. Discovery of clinical candidate Sivopixant (S-600918): Lead optimization of dioxotriazine derivatives as selective P2X3 receptor antagonists [published online ahead of print, 2021 Sep 26]. Bioorg Med Chem Lett. 2021;52:128384.
molnova catalog



related products
-
Biotin-PEG4-Amide-C6...
Biotin-PEG4-Amide-C6-Azide is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
Glycyl-L-Histidyl-L-...
Glycyl-L-histidyl-L-lysine is a liver cell growth factor and an asynthetic hepatotrophic agent that stimulates hepatic erythropoietic factor production.
-
Pomalidomide-C7-NH2 ...
Pomalidomide-C7-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology.